Red top companies emerge behind profiteering drugs

We hope that the media to properly analyze this matter, simply the entire interest chain to uncover, see the drug profiteering in the end who took away!　　In our opinion, the company is on behalf of the government departments in the procurement of drugs for us, as to the background of the company, we do not know. --a press spokesperson of Hunan-ya er hospital a factory-price 15.5 yuan of drugs, after many links sold to the patient's hands, prices rose to 213 yuan, the profit reached 1300%.　　Hunan Province, the second hospital, "profiteering drug" incident by the media exposure, aroused the strong concern of all sectors of society. Xiang Ya Second hospital officials briefed reporters yesterday on some aspects of the hospital's pharmaceutical procurement, and said the hospital in this incident is also "victims."　　With the in-depth interview, the reporter found that the matter behind the "water is very deep", is not a high price of medicine so simple. Drug profits as high as 1300% ex-factory price of 15.5 yuan Hospital sold 213 Yuan Changsha of the South Korean woman had ovarian cancer six months ago, in the two hospitals in Xiang ya did chemotherapy. The doctor advised her to take a cancer-adjuvant asparagus pill. This medicine is produced by Sichuan West China Pharmaceutical Co., Ltd., the hospital price of 213 yuan per bottle.　　Han asked that this piece of asparagus is only 30 yuan per bottle. After the approval of the price Bureau of the matter exposed, Xiang ya second hospital drug purchasing director Zhou to the media, the price of 213 yuan is the country set. All drug prices in the hospital have been approved by the price department of Hunan province, and the procurement according to the provisions of bidding.　　According to Zhou introduced, asparagus tablets tender price of 185.22 yuan per bottle, "We shun Plus is 15 points, 213 yuan". According to a list of sales from a pharmaceutical company, asparagus tablets were sold from a pharmaceutical company to a hospital, with prices rising from thirty or forty to 136 yuan. The price list of the asparagus slice in the warehouse shows that a bottle of asparagus is purchased from the factory and the price is only 15.5 yuan.　　In other words, the hospital price is 7 times times the wholesale price, is 14 times times the ex-factory prices. What exactly is the problem of drug profits reaching 1300%?　　In the face of surging public opinion, Hunan Province authorities began to respond. May 17, Hunan Provincial Price Bureau Deputy Inspector Guo Zhih said that the asparagus tablets in 2004 into the health care directory in Hunan province, the November 2006 Hunan Provincial Price bureau based on the relevant information provided by enterprises to develop the maximum retail price of 160 yuan per box.　　In 2007, the Hunan Provincial Price bureau adjusted the maximum retail price of the drug to 213 yuan per box according to the prices provided by the price Department of the drug producing place.　　Not through the bidding process according to Guo Zhih introduced, the asparagus film is exclusive production, manufacturers only for hospitals, no retail pharmacy sales price for reference, Hunan Provincial Price bureau this year, referring to the surrounding provinces in 2008, the actual implementation of the bid price, the initial determination of the variety of drug prices for the price of each box 136 yuan Guo Zhih said that if the drug needs to enter the public hospital sales must go through the bidding process. The drug has not been involved in the procurement of drugs in Hunan province, so it can not be sold in public hospitals. At present, this medicine is 185.2 per carton2 Yuan Price appears in the bidding platform directly linked to purchase, the department is illegal.　　Hunan Provincial Price Bureau will cooperate with relevant departments in this investigation. "Profiteering" hospital big call "wronged" "our hospital profit is actually only 15%" "We are wronged, the hospital is also the victim of the incident."　　Yesterday, the reporter came to Xiang ya Second hospital interview, hospital staff are crying "wronged." Must be from the company procurement "We hope that the media to properly analyze this matter, simply the entire interest chain to uncover all, see the drug profiteering in the end who took away!" Xiang Ya Second Hospital Medical department director, spokesman Chen Jindong told reporters.　　Chen Jindong to reporters about the hospital drug procurement procedures. If we need some kind of medicine in our hospital, we must go through the tender purchase of Hunan Zhenhua Pharmaceutical Electronic Commerce Co., Ltd. If the purchase, it will be identified as illegal violations, will be severely punished. After the purchase of medicines, we can only float 15% on the basis of the original medicine price.　　Chen Jindong said the hospital's profits are actually only 15%. According to the reporter understand, in order to standardize the online procurement of drug prices, in December 2009, the Hunan Provincial price bureau, "Hunan Province online centralized procurement of drug price management measures (trial)", the provincial government-sponsored grassroots health institutions to implement the basic drug system, County and county and above the public medical institutions are all online centralized procurement of drugs.　　In Changsha, all the provincial and ministerial hospital procurement of drugs must be through Hunan Zhenhua Pharmaceutical Electronic Commerce Co., Ltd. for tender procurement.　　Reporter in its official online see, Hunan Zhenhua Pharmaceutical Electronic Commerce Co., Ltd. was founded in August 2001, is the first established in Hunan Province through the certification of drug tendering agency, mainly engaged in pharmaceutical online bidding agent services, pharmaceutical online procurement services, medical information consulting services. The middle link took away the profit can be seen in many large hospitals in Changsha, Zhen Xiang is a representative of the government Department of the "Red Top" company. "In our view, the company is on behalf of the government Department in the procurement of drugs for us, as to what the background of the company, we do not know."　　Chen Jindong reluctantly said.　　Chen Jindong said, why the price of asparagus tablets so high, they also do not know, the hospital is not a lot of profits, the main profit or by the middleman to take away. Who's making a huge profit? Designated pharmaceutical companies will inevitably breed new corruption according to reporters understand, in order to supervise drug procurement, "Hunan Province online procurement of drug price management measures (trial)" stipulates that the provincial people's government price administrative departments responsible for the establishment of the province online centralized procurement of drug prices management measures, And the drug online centralized procurement activities in the price behavior supervision, the online centralized procurement of drugs for the legality of the bid price audit, and is responsible for the online procurement of drugs to purchase price guidance prices, the successful acceptance of the retail prices of the audit and release work. The price administrative department of the Counties (districts) in each city is responsible for participating in the online concentrationTo supervise and inspect the price behavior of the parties involved in purchasing drugs (including medical institutions, pharmaceutical production and distribution enterprises). "In practice, there is still room for government supervision, so that some drugs are surprisingly expensive."　　People familiar with the matter said. Guo Zhih in the notification of "profiteering gate" incident also admitted that in the price of asparagus tablets approved issues, the price Bureau staff do not strictly control the problem,　　Pricing is not aware of the 15.5 yuan per box of ex-factory price and a box of 30~40 yuan of pharmaceutical companies to purchase prices and other important information, resulting in the production of 136 yuan per box bid price is high. "The intention of the designated pharmaceutical companies to tender is to prevent corruption in the procurement of drugs, but in the case of supervision is not in place, as the intermediary nature of pharmaceutical agencies will inevitably not produce new corruption."　　People familiar with the matter are deeply concerned. Why can a drug without a bidding procedure be directly linked to the sale? Does Xiang ya er hospital have a doctor to collect kickbacks? Who was it that made huge profits?　　It is reported that at present, in addition to the Hunan-ya second hospital is carrying out self-examination, Hunan province Shing, the Department of Health, Drug Administration, discipline inspection and other departments have formed a joint investigation team to investigate the matter. The Law daily Feeds